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Abstract
The transport of dipeptides and h-lactam antibiotics across the rat renal basolateral membrane was examined. The initial uptake of
glycylsarcosine and cefadroxil by rat renal basolateral membrane vesicles was inhibited by the presence of all the di- and tripeptides and h-
lactam antibiotics that were tested in this study. However, the uptake of both substrates was not inhibited by glycine, an amino acid. The
initial uptake of zwitterionic h-lactam antibiotics, cefadroxil, cephradine, and cephalexin, was stimulated by preloaded glycylsarcosine
(countertransport effect). On the other hand, the uptake of dianionic h-lactam antibiotics, ceftibuten and cefixime, was not affected. A
concentration-dependent initial uptake of glycylsarcosine and cefadroxil suggested the existence of a carrier-mediated mechanism, whereas
the transport of ceftibuten did not show any saturated uptake. The transporter that participates in the permeation of dipeptides and h-lactam
antibiotics across basolateral membranes showed lower affinity than did PEPT1 and PEPT2. This is the first study that showed an evidence
for a peptide transporter, expressed in the rat renal basolateral membrane, that recognizes zwitterionic h-lactam antibiotics using basolateral
membrane vesicles isolated from normal rat kidney.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Peptide transporters expressed in brush-border mem-
branes of intestinal and renal epithelial cells contribute to
the efficient absorption and reabsorption of oligopeptides. It
is known that the dipeptide transport system in renal tubular
epithelial cells contributes to reabsorption of severalh-lactam
antibiotics in the kidney [1,2]. In the brush-border membrane,
it has been demonstrated that peptides are transported by H+-
coupled co-transport systems [3]. The results of experiments
using purified brush-border membrane vesicles from the rat
kidney cortex suggest that there are at least two distinct
peptide transporters in the brush-border membranes of renal
proximal tubules and that these dipeptide transporters also
recognize h-lactam antibiotics [4–6]. Furthermore, molec-
ular cloning studies have revealed the existence of the two
distinct peptide transporters, PEPT1 [7] and PEPT2 [8].
In contrast to the brush-border membrane, there is little
functional and molecular information available on the pep-
tide transport system localized at the basolateral membranes
in the kidney. Terada et al. [9] suggested the existence of a
novel peptide transporter in renal basolateral membranes
based on the results of experiments using Mardin–Darby
canine kidney (MDCK) cells. However, there are few
reports about the transport mechanism of dipeptides and
h-lactam antibiotics across basolateral membranes of epi-
thelial cells using normal tissue.
In the present study, characteristics of the transport of
peptide and h-lactam antibiotics as well as a dipeptide,
glycylsarcosine, across the rat renal basolateral membrane
were investigated using isolated basolateral membrane
vesicles prepared from the renal proximal tubule.
2. Materials and methods
2.1. Materials
Ceftibuten (Shionogi, Osaka, Japan) and cefixime (Fuji-
sawa Pharmaceutical, Osaka, Japan) were kindly donated.
[3H]Glycylsarcosine (92.8 GBq/mmol) was purchased from
0005-2736/02/$ - see front matter D 2002 Elsevier Science B.V. All rights reserved.
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Moravec Biochemicals (Brea, CA). All the other chemicals
were of the highest grade available and were used without
further purification.
2.2. Preparation of basolateral membrane vesicles
Basolateral membrane vesicles were isolated according
to the self-orienting Percoll-gradient centrifugation method
of Kobayashi et al. [10] with minor modifications for the
renal cortex. Kidneys were excised from adult male Wistar
rats, 180–250 g, under anesthesia (50 mg/kg sodium
pentobarbital, i.p.) and rinsed with ice-cold saline. All the
following procedures were performed on ice or at 4 jC. The
renal cortex was sliced and homogenized for 4 min at 16500
rpm with a blender (Ace Homogenizer, Nihonseiki Seisa-
kusho, Tokyo, Japan) in 80 ml of an ice-cold buffer
containing 250 mM sucrose, 0.1 mM phenylmethylsulfonyl
fluoride, and 10 mM triethanolamine/HCl, pH 7.5 (solution
A). The homogenate was centrifuged for 15 min at
1500 g, and the supernatant was recentrifuged for 20
min at 20500 g. The fluffy upper layer was collected,
resuspended in 28.2 ml of solution A containing 12%
Percoll, and homogenized with a glass/Teflon Dounce-type
homogenizer with 10 strokes. The crude membrane suspen-
sion was centrifuged for 60 min at 50,000 g. The third
fraction from the bottom (approximately 10 ml) was with-
drawn and diluted to 32 ml of a buffer consisting of 100 mM
D-mannitol, 100 mM KCl, 5 mM EGTA, and 20 mM
HEPES/Tris pH 7.5 (solution B). After centrifugation of
this fraction for 30 min at 48,000 g, the pellet was
collected and resuspended in 20-ml solution B, and MgCl2
was added to a final concentration of 10 mM. The baso-
lateral membrane was precipitated by centrifugation for 15
min at 3400 g. The pellet was suspended in 20 ml of a
buffer (experimental buffer; 100 mM D-mannitol, 100 mM
KCl, 20 mM HEPES/Tris pH 7.5) and homogenized in a
glass/Teflon Dounce-type homogenizer with 10 strokes.
After a final centrifugation at 27,000 g for 30 min, baso-
lateral membrane vesicles were suspended in the experi-
mental buffer by passing through a fine needle (0.4 19
mm) with a glass syringe 10 times. Basolateral membrane
vesicles were used for transport studies within 4 h after
preparation.
2.3. Uptake experiments
Uptake experiments were performed at 25 jC according
to the method of Sugawara et al. [11]. The reaction was
initiated by mixing 40 Al of membrane vesicle suspension
with 200 Al of the transport buffer (unless otherwise stated,
the transport buffer was composed of 100 mM D-mannitol,
100 mM KCl, and 20 mM HEPES/Tris, pH 7.5) containing
substrates. Then, after a determined time, the reaction was
terminated by diluting the reaction mixture with 5 ml of ice-
cold stop buffer (150 mM KCl, 20 mM HEPES/Tris, pH
7.5) followed by filtration through a Millipore filter (HAWP,
0.45 Am, 2.5-cm diameter). The filter was then washed once
with 5 ml of the ice-cold stop buffer. h-Lactam antibiotics
trapped on the filter were extracted with 300 Al of distilled
water.
The countertransport effect was examined by the method
of Muranushi et al. [12] with minor modifications. Mem-
brane vesicles were suspended in the experimental buffer
solution to a final concentration of about 20 mg protein/ml.
A portion of the vesicle suspension (20 Al) was preloaded
with 20 Al of the experimental buffer solution containing 20
mM of glycylsarcosine for 30 min at 25 jC, and then the
uptake experiment was carried out as described above.
2.4. Analytical procedures
The detection of h-lactam antibiotics trapped on the filter
was carried out using high-performance liquid chromatog-
raphy as previously reported [13]. Separation of h-lactam
antibiotics was carried out on a reversed phase column
(ODS Hitachi #3053) using a mobile phase of 12% acetoni-
trile containing 0.05 M citric acid and 0.01 M KCl with pH
adjusted to 2.5 with NaOH. For the separation of cephradine
and cephalexin, 20% acetonitrile containing 0.04 M citric
acid and 0.08 M KCl (pH 2.5) was used. The flow rate and
the detection wavelength were 0.7 ml/min and 262 nm,
respectively. [3H]Glycylsarcosine was measured by liquid
scintillation counting. The uptake value was normalized
with the amount of membrane protein. The concentration
of membrane protein was measured by the method of Lowry
et al. [14] with bovine serum albumin as a standard. The
activity of Na+, K+-ATPase was measured by the method of
Proverbio and Del Castillo [15]. Alkaline phosphatase
activity was assayed using an Alkaline Phospha K-test kit
(Wako Pure Chemical Industries, Osaka, Japan). The results
are expressed as meanF S.E. Student’s t test was used to
determine the statistical significance, and P values less than
0.05 were considered significant.
3. Results and discussion
3.1. Enzyme activity and transport activity of membrane
vesicles
To confirm the purity and transport function of the
membrane vesicles, we examined the activity of marker
enzyme and transport of typical substrates that are trans-
ported through basolateral membrane via active transporters.
The enrichment factors for the respective marker enzyme of
renal basolateral and brush-border membranes, Na+, K+-
ATPase, and alkaline phosphatase were calculated. The
activity of Na+, K+-ATPase in the basolateral membrane
was 7.4 times higher than that in the renal cortex homoge-
nate, whereas the activity of alkaline phosphatase showed
only 1.3 times of enrichment. To confirm that the basolateral
membrane forms vesicles, the equilibrium uptake (60 min) of
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cefadroxil was assessed at various transmembrane osmotic
gradients. As shown in Fig. 1, the uptake of cefadroxil
decreased with an increase in medium osmolarity, indicating
formation of vesicles. Extrapolation of the fitted line to the
vertical axis showed slight adsorption of cefadroxil to the
basolateral membrane vesicles.
We also examined the activity of known transporters in
the rat renal basolateral membrane according to the method
of Pritchard [16]. The uptake of p-aminohippuric acid
(PAH; a typical substrate for an organic anion transporter)
by renal basolateral membrane vesicles in the presence of an
inward Na+ gradient and glutaric acid was examined.
Stimulation of the uptake of PAH by an inward gradient
of Na+ and glutaric acid was observed (Fig. 2). Glutaric acid
would be concentrated by Na+-dependent dicarboxylate
cotransporter-1 (NaDC-1) into the vesicle, and this would
be followed by exchange of PAH for glutarate via organic
anion transporter-1 (OAT-1) [16]. Therefore, it was shown
that the basolateral membrane vesicles prepared in this study
were adequate to examine the function of transporters in the
basolateral membrane.
3.2. Effects of peptides and b-lactam antibiotics on the
uptake of glycylsarcosine and cefadroxil by basolateral
membrane vesicles
To characterize the transport of glycylsarcosine in the
renal basolateral membrane, the inhibitory effects of gly-
cylsarcosine, alanylalanine, and h-lactam antibiotics were
examined. The uptake of glysylsarcosine was inhibited by
all of the tested compounds, and the degrees of the inhib-
ition were almost the same (Table 1). We also examined the
effects of di- and tripeptides, h-lactam antibiotics, and
glycine, an amino acid, on the uptake of cefadroxil by the
renal basolateral membrane. As shown in Table 2, the
uptake of cefadroxil was inhibited by all of the peptides
and h-lactam antibiotics. On the other hand, glycine did not
show any effect. These results suggest that a transporter that
recognizes both peptides and h-lactam antibiotics is
expressed in the renal basolateral membrane. In this study,
there was no driving force in any of the experiments. There
is no H+ gradient on the basal side of epithelial cells which
is a driving force for the transporters PEPT1 and PEPT2
expressed in the brush-border membrane. Moreover, the
uptake of cefadroxil by basolateral membrane vesicles was
not affected by an inward Na+ gradient (not shown). There-
fore, although a role of H+ gradient should be examined
further, it is possible that glycylsarcosine and cefadroxil are
transported via a facilitative transport system.
Fig. 1. Uptake of cefadroxil as a function of osmolarity of the extravesicular
medium. Membrane vesicles (40 Al) were suspended in 100 mM KCl, 100
mM D-mannitol, and 20 mM HEPES/Tris, pH 7.5. Uptake study was
performed by adding an incubation medium (200 Al) consisting of 100 mM
KCl, 100 mM D-mannitol, and 20 mM HEPES/Tris, pH 7.5 containing 0–
270 mM D-cellobiose. The uptake was performed at 25 jC, and the
concentration of cefadroxil was 1 mM. Each point represents the
meanF S.E. (n= 9) from three different preparations.
Fig. 2. Effects of inward gradient of Na+ and glutaric acid (GA) on the
uptake of p-aminohippuric acid (PAH; 2 AM) by rat renal basolateral
membrane vesicles. Membrane vesicles (40 Al) were suspended in 100 mM
KCl, 100 mM D-mannitol, and 20 mM HEPES/Tris (pH 7.5). Uptake study
was performed by adding a buffer (200 Al) containing 100 mM NaCl, 100
mM D-mannitol, 12 AM gllutaric acid, and 20 mM HEPES/Tris (pH 7.5)
with 2.4 AM p-aminohippuric acid. Medium temperature was 25 jC. Each
column represents the meanF S.E. (n= 10) from three different prepara-
tions of vesicles. The symbol (***) indicates significant difference from the
control ( P< 0.001).
Table 1
Effects of dipeptides and h-lactam antibiotics on the uptake of
[3H]glycylsarcosine by rat renal basolateral membrane vesicles
Inhibitor Uptake (percent of control)
None (control) 100.0F 5.6
Gly–Sar 45.0F 4.8***
Ala–Ala 39.2F 4.5***
Cefadroxil 58.8F 2.4***
Ceftibuten 53.0F 5.9***
Cephradine 46.5F 5.9***
Cephalexin 47.5F 4.6***
Membrane vesicles (40 Al) were suspended in 100 mM KCl, 100 mM D-
mannitol and 20 mM HEPES/Tris buffer, pH 7.5. Uptake was performed by
adding the buffer (200 Al) containing 24 AM [3H]glycylsarcosine in the
absence (control) or presence of 24 mM of an inhibitor at 25 jC for 2 min.
Each value represents the meanF S.E. (n = 9) from three different
preparations of vesicles. The symbol (***) indicates significant difference
from the control ( P < 0.001).
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3.3. Countertransport effects of glycylsarcosine on the
uptake of b-lactam antibiotics by basolateral membrane
vesicles
Countertransport (trans-stimulation) effects of glycylsar-
cosine on the uptake of various h-lactam antibiotics were
examined (Fig. 3). The uptake of cefadroxil, cephradine,
and cephalexin was stimulated in vesicles preloaded with
glycylsarcosine. On the other hand, the uptake of ceftibuten
and cefixime was not affected. These results suggest that h-
lactam antibiotics that have h-amino groups in their mole-
cules shared a common transporter, whereas ceftibuten and
cefixime, di-anionic compounds, are not transported.
Although ceftibuten and cefixime, as well as cefadroxil,
are well-known substrates for PEPT1 and PEPT2, they have
different structures [17]. These results suggest that it is
important that an a-amino moiety be transported via a
transporter common to dipeptides such as glycylsarcosine.
3.4. Kinetics of the transport of glycylsarcosine, cefadroxil,
and ceftibuten by renal basolateral membrane vesicles
The concentration dependence of the initial uptake (2
min) of glycylsarcosine, cefadroxil, and ceftibuten by rat
renal basolateral membrane vesicles was studied (Fig. 4).
The uptake of glycylsarcosine and cefadroxil was saturated
with an increase in concentration (Fig. 4A and B), whereas
that of ceftibuten was not (Fig. 4C). The kinetic parameters
of glycylsarcosine and cefadroxil were estimated by non-
linear least-squares regression analysis using the following
equation:
v ¼ Vmax  ½S=ðKm þ ½SÞ þ Kd  ½S
where v is the uptake amount (pmol/mg protein/2 min), [S]
is the concentration of the substrate (mM), Km is the
Mechaelis–Menten constant (mM), Vmax is the maximum
transport rate of the saturated part, and Kd is the rate
constant of nonsaturated permeation (nl/mg protein/2
min). For glycylsarcosine, Km, Vmax, and Kd were estimated
to be 8.0F 4.1 (mM), 1620F 760 (pmol/mg protein/2 min),
and 136.7F 19.6 (nl/mg protein/2 min), respectively. For
cefadroxil, they were estimated to be 10.4F 5.3 (mM),
2126F 1083 (pmol/mg protein/2 min), and 27.4F 24.2
(nl/mg protein/2 min), respectively. The kinetic parameters
for the saturated process were similar between glycylsarco-
sine and cefadroxil, and nonsaturated permeation of glycyl-
sarcosine was greater than that of cefadroxil.
Terada et al. [17] estimated the Ki value of the inhibitory
effect of cefadroxil on the uptake of glycylsarcosine using
LLC-PK1 cells that stably express PEPT1 or PEPT2, which
are expressed on the brush-border membranes of renal
epithelial cells. The estimated Ki values for PEPT1 and
PEPT2 were 2.1 mM and 3 AM, respectively. The Km values
of glycylsarcosine for PEPT1 and PEPT2 were 1.1 and 0.11
mM, respectively. As shown in this study, the affinities of
glycylsarcosine and cefadroxil for the system that partic-
ipates in the transport across the basolateral membrane were
much lower than those for PEPT1 and PEPT2. Moreover,
the uptake of ceftibuten by basolateral membrane vesicles
did not saturate, although it is transported via both PEPT1
and PEPT2. The results of this study clearly showed a
difference between substrate specificities of transporters
expressed on the brush-border and basolateral membranes.
Fig. 3. Countertransport effects of Gly–Sar on the uptake of various h-
lactam antibiotics by rat renal basolateral membrane vesicles. Membrane
vesicles (40 Al) were preincubated at 25 jC for 30 min in 100 mM KCl, 100
mM D-mannitol, and 20 mM HEPES/Tris buffer, pH 7.5, in the absence
(control) or presence (with Gly–Sar) of 10 mM Gly–Sar. Uptake was
performed by adding the buffer (200 Al) containing 1.2 mM h-lactam
antibiotic in the presence (control) or absence (with Gly–Sar) of 2 mM
glycylsarcosine (final concentration of Gly–Sar outside the vesicles being
1.7 mM). Medium temperature was 25 jC. Each column represents the
meanF S.E. (n= 9) from three different preparations of vesicles. The
symbol (***) indicates significant difference from the control ( P < 0.001).
Table 2
Effects of peptides, glycine and h-lactam antibiotics on the uptake of
cefadroxil by rat renal basolateral membrane vesicles
Inhibitor Uptake (percent of control)
Peptides or glyciney
None (control) 100.0F 9.2
Gly–Sar 74.1F 5.4**
Gly–Pro 65.1F 7.1***
Phe–Ala 78.3F 3.6*
Ala–Ala 58.5F 7.6***
Phe–Gly–Gly 73.9F 6.6**
Gly 111.7F 2.5
h-lactam antibioticsyy
None (control) 100.0F 4.6
Cephalexin 65.2F 5.4***
Cefixime 78.3F 5.8**
Membrane vesicles (40 Al) were suspended in 100 mM KCl, 100 mM D-
mannitol and 20 mM HEPES/Tris buffer, pH 7.5. Uptake was performed by
adding the buffer (200 Al) containing 1.2 mM cefadroxil in the absence
(control) or presence of 24 mM of an inhibitor either at 37 jC for 5 miny or
at 25 jC for 2 minyy. Each value represents the meanF S.E. (n= 9) from
three different preparations of vesicles. The symbols (*), (**), and (***)
indicate significant differences of P < 0.05, P < 0.01, and P < 0.001 from the
control, respectively.
M. Sugawara et al. / Biochimica et Biophysica Acta 1609 (2003) 39–4442
Terada et al. [18] and Sawada et al. [19] estimated the Km
value of the transport (uptake) of glycylsarcosine through
the basolateral membrane using MDCK cells cultured on a
porous filter. They also estimated Ki values of inhibitory
effects of ceftibuten and cefadroxil on the uptake of gly-
cylsarcosine. The Km value of the uptake of glycylsarcosine
was estimated to be 74 AM, and the Ki values of ceftibuten
and cefadroxil were estimated to be 2.1 mM and 1 AM,
respectively. In the present study, however, Km values of
glycylsarcosine and cefadroxil were estimated to be 8.0 and
10.4 mM, respectively. These values are very different from
the values in MDCK cells. We did not examine the Ki value
of the inhibitory effect of ceftibuten on the uptake of
glycylsarcosine. However, the data on uptake of ceftibuten
by basolateral membrane vesicles suggest that ceftibuten is
not transported by the common system to glycylsarcosine
and cefadroxil because the uptake of ceftibuten does not
saturate up to 20 mM. Although there is great difference in
kinetic parameters, there are two similar points between the
transporter that was suggested by the results of experiments
using MDCK cells and that in this study. One point is that
both transporters were inhibited by dipeptides and h-lactam
antibiotics but not by amino acid, and the other is that
cefadroxil had higher affinity than did ceftibuten. At this
stage, we do not know the reason for the differences in Km.
Difference in experimental conditions or in species might be
a reason.
In this study, Km values of the transport of glycylsarco-
sine and cefadroxil were 8.0 and 10.4 mM, respectively.
Although we did not examine the transport of these com-
pounds via organic anion transporters, these values are
larger than reported Ki values of cloned rat organic anion
transporters for h-lactam antibiotics [20,21]. Moreover,
kinetic analysis showed that the uptake of these substrates
fitted with one phase Michaelis–Menten equation and there
was no higher affinity phase. Therefore, we concluded that
the contribution of organic anion transporters is very small
in this experimental condition.
In the kidney, the active glucose transporters SGLT1 and
SGLT2 (sodium-dependent glucose transporters [22,23]),
which have high affinity and low capacity, are expressed
in the brush-border membrane of the proximal tubule. In the
basolateral membrane, on the other hand, the facilitative
glucose transporter GLUT2 [24,25], which has low affinity
and high capacity, is expressed. The basolateral transporter
that was characterized in the present study also has low
affinity and high capacity compared to the transporter in the
brush-border membrane. The peptide transporter expressed
in basolateral membrane might have similar function to
GLUT2 in reabsorption of peptides. However, if the trans-
port of peptides is coupled with proton like PEPT1 and
PEPT2 is still unclear. In the intestine it is reported that the
transport of glycylproline across basolateral membrane is
driven by proton gradient [26]. Therefore, it is possible that
proton works as a driving force although it may not work
concentrative in physiological condition. Further study
should be done to clarify this point.
In summary, this is the first report on transport character-
istics of dipeptides and h-lactam antibiotics, determined
using basolateral membrane vesicles prepared from the rat
kidney. The results suggest that there is a transporter that
transports dipeptides and zwitterionic h-lactam antibiotics
across the rat renal basolateral membrane. This transporter,
however, does not transport dianionic h-lactam antibiotics
such as ceftibuten. They are likely blockers of the trans-
porter rather than substrates. So far, no peptide transporter
other than PEPT1 and PEPT2 that is expressed on the brush-
border membrane of epithelial cells has been cloned. Further
molecular biological studies are needed to elucidate the
transport characteristics in the basolateral membrane.
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